Categories Automotive

Pivot Point Strategies Files to Advocate on Eight Key Issues

Why It Matters

Pivot Point Strategies LLC is active in lobbying on a range of critical issues, including trade, tariffs, healthcare spending cuts, and automotive regulations. As an in-house lobbying operation, the firm advocates for its own interests, rather than those of external clients.

This registration indicates a significant commitment to federal lobbying amid complex policy challenges such as tariff disputes impacting manufacturing, Medicaid cuts approved for 2025, and ongoing renegotiations of trade agreements that will continue until 2026.

By the Numbers

Pivot Point Strategies LLC registered on August 28, reporting no lobbying revenue for the year leading up to that date, and it did not specify any legislation in its filing.

Amandine Schneickert is the firm’s registered lobbyist. Before this, she worked in Federal Government Affairs for Robert Bosch LLC in 2025, focusing on automotive, trade, taxation, energy, manufacturing, and telecommunications. During that time, Robert Bosch reported lobbying expenses of $230,000 in the first quarter of 2025.

Broader Context

The automotive and medical device industries are currently facing significant challenges that align with the issues prioritized by Pivot Point Strategies.

In 2025, the Trump administration implemented a 25% Section 232 tariff on imported vehicles and parts, leading to costs of $35 billion for the automotive sector. Due to the fact that nearly 75% of U.S. medical devices are imported, industry leaders are concerned that tariffs may hinder innovation and exacerbate supply shortages.

Additionally, the U.S. opted not to extend the United States-Mexico-Canada Agreement (USMCA), initiating an annual review process until 2036. Canada is particularly focused on removing U.S. tariffs on steel, aluminum, automobiles, and lumber, while Congress retains a consultative role in the upcoming 2026 review.

The budget reconciliation legislation enacted in 2025 also includes substantial cuts to federal Medicaid spending, totaling nearly $1 trillion over the next decade, while reducing federal Marketplace expenditures by $49.5 billion over the same period.

For more detailed insights, access the Legis1 platform for comprehensive political news, data, and insights.

If you see any inaccuracies, please report an issue with this article.

Leave a Reply

您的邮箱地址不会被公开。 必填项已用 * 标注

You May Also Like